SORRENTO THERAPEUTICS (SRNE) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 155 252 sessions, September 29, 2025 to September 29, 2026
- Largest daily move
- +170% close of December 24, 2025
- 1-year change
- -77.1% closing prices, September 29, 2025 to September 29, 2026
Company Description
SORRENTO THERAPEUTICS (OTC: SRNE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.9M.
SRNE has declined 77.1% over the past year. The last closing price was $0.0008.
For FY2022, SORRENTO THERAPEUTICS reported revenue of $62.8M with net income of -$572.8M and diluted earnings per share of -$1.37. The company operates at a net profit margin of -911.6%.
This page collects what Stock Titan holds for SRNE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SORRENTO THERAPEUTICS (SRNE) closed at $0.0008 on September 29, 2026. Over the past 12 months, the price has lost 77.1%.
SRNE Metrics & Rankings
Price returns through September 29, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SORRENTO THERAPEUTICS has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include dividends, acquisition, fda approval. View all SRNE news →
SEC Filings
Financial Highlights
SORRENTO THERAPEUTICS generated $62.8M in revenue in FY2022, operating income reached -$504.3M (-802.5% operating margin), and net income was -$572.8M, reflecting a -911.6% net profit margin. Diluted earnings per share stood at -$1.37. The company generated -$293.9M in operating cash flow. The current ratio was 0.29, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in SORRENTO THERAPEUTICS (SRNE) currently stands at 3.5 million shares, representing 0.6% of the float.
Days to Cover History
Days to cover for SORRENTO THERAPEUTICS (SRNE) currently stands at 21.3 days, up 17.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since September 2025, the figure has increased by 48.8%. Across the settlements charted above, it has ranged from 1.0 to 27.2 days.
SRNE Company Profile & Sector Positioning
SORRENTO THERAPEUTICS (SRNE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing SRNE often look at related companies in the same sector, including AIM IMMUNOTECH INC (AIMI), ENZOLYTICS INC (ENZC), NEON BLOOM INC (NBCO), GREY MATTERS HEALTH INC (AGNPF), and AXIM BIOTECHNOLOGIES INC (AXIM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SRNE's relative position within its industry.